ArticleCancers2022

Classic Hodgkin Lymphoma Refractory for ABVD Treatment Is Characterized by Pathologically Activated Signal Transduction Pathways as Revealed by Proteomic Profiling.

Bent Honoré et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.